BOVEN trial

GPTKB entity

Statements (57)
Predicate Object
gptkbp:instanceOf clinical trial
gptkbp:aimsTo improve patient outcomes
optimal dosage
gptkbp:analyzes long-term effects
gptkbp:associated_with patient recruitment strategies
improved treatment protocols
improved patient safety measures
gptkbp:collaborates_with academic institutions
gptkbp:conducted medical researchers
gptkbp:focusesOn treatment efficacy
gptkbp:follows ethical guidelines
gptkbp:has multiple phases
exclusion criteria
inclusion criteria
https://www.w3.org/2000/01/rdf-schema#label BOVEN trial
gptkbp:includes placebo group
gptkbp:influenced patient feedback
gptkbp:involves monitoring patient health
patients with specific conditions
gptkbp:is_a_subject_of peer review
gptkbp:is_aimed_at reducing healthcare costs
specific demographic groups
gptkbp:is_designed_to quality of life
clinical practice
therapeutic strategies
patient adherence
different treatment modalities
new_therapeutic_approaches
gptkbp:is_expected_to clinical guidelines
medical knowledge
regulatory approvals
health policy decisions
data for future research
existing treatment methods
new insights into treatment
gptkbp:is_funded_by government grants
gptkbp:is_governed_by institutional review board
gptkbp:is_monitored_by safety and efficacy
gptkbp:is_part_of evidence-based medicine
clinical research networks
multinational studies
clinical trial phases.
larger research initiative
gptkbp:is_studied_in data scientists
cost-effectiveness
statistical significance
gptkbp:isPublishedIn medical journals
gptkbp:measures adverse effects
gptkbp:performedBy various healthcare settings
strict regulatory oversight
gptkbp:recruitment participants from multiple sites
gptkbp:registration clinical trial databases
gptkbp:reportsTo clinical trial registries
clinical trial registrars
gptkbp:sponsor pharmaceutical companies
gptkbp:uses randomized control methodology
gptkbp:utilizes biostatistical analysis